Linda H. Zetterlund - Publications

Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655).

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 10, 2025

Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study.

Journal: Breast cancer research and treatment

Published: July 16, 2023

Long-term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status.

Journal: The British journal of surgery

Published: March 29, 2020

Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.

Journal: Breast cancer research and treatment

Published: February 12, 2017

Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.

Journal: Breast cancer research and treatment

Published: February 12, 2017

Lymphatic Drainage in the Breast Before and Up to Five Years After a Reduction Mammaplasty.

Journal: Lymphology

Published: September 01, 2016

Impact of previous surgery on sentinel lymph node mapping: Hybrid SPECT/CT before and after a unilateral diagnostic breast excision.

Journal: Breast (Edinburgh, Scotland)

Published: May 22, 2016

Incidence of and risk factors for sentinel lymph node metastasis in patients with a postoperative diagnosis of ductal carcinoma in situ.

Journal: The British journal of surgery

Published: November 14, 2013